POS-832 DAPAGLIFLOZIN IN IgA NEPHROPATHY: FINDINGS FROM THE DAPA-CKD TRIAL
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-04-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024921010160 |
| _version_ | 1818458020124819456 |
|---|---|
| author | H. Lambers Heerspink R.D. Toto N. Jongs P. Vart G.M. Chertow F.F. Hou J.J.V. McMurray R. Pecoits-Filho R. Correa-Rotter P. Rossing C.D. Sjöström B.V. Stefánsson K. Umanath A.M. Langkilde D.C. Wheeler |
| author_facet | H. Lambers Heerspink R.D. Toto N. Jongs P. Vart G.M. Chertow F.F. Hou J.J.V. McMurray R. Pecoits-Filho R. Correa-Rotter P. Rossing C.D. Sjöström B.V. Stefánsson K. Umanath A.M. Langkilde D.C. Wheeler |
| author_sort | H. Lambers Heerspink |
| collection | DOAJ |
| first_indexed | 2024-12-14T22:51:49Z |
| format | Article |
| id | doaj.art-232a44322a6e491e861c6bb2b372887d |
| institution | Directory Open Access Journal |
| issn | 2468-0249 |
| language | English |
| last_indexed | 2024-12-14T22:51:49Z |
| publishDate | 2021-04-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Kidney International Reports |
| spelling | doaj.art-232a44322a6e491e861c6bb2b372887d2022-12-21T22:44:41ZengElsevierKidney International Reports2468-02492021-04-0164S362POS-832 DAPAGLIFLOZIN IN IgA NEPHROPATHY: FINDINGS FROM THE DAPA-CKD TRIALH. Lambers Heerspink0R.D. Toto1N. Jongs2P. Vart3G.M. Chertow4F.F. Hou5J.J.V. McMurray6R. Pecoits-Filho7R. Correa-Rotter8P. Rossing9C.D. Sjöström10B.V. Stefánsson11K. Umanath12A.M. Langkilde13D.C. Wheeler14University of Groningen University Medical Center Groningen, Department Clinical Pharmacy and Pharmacology, Groningen, NetherlandsUT Southwestern Medical Center, Department of Internal Medicine, Dallas, United StatesUniversity of Groningen University Medical Center Groningen, Department Clinical Pharmacy and Pharmacology, Groningen, NetherlandsUniversity of Groningen University Medical Center Groningen, Department Clinical Pharmacy and Pharmacology, Groningen, NetherlandsStanford University School of Medicine, Departments of Medicine and Epidemiology and Population Health, Stanford, United StatesNanfang Hospital- Southern Medical University- National Clinical Research Center for Kidney Disease, Division of Nephrology, Guangzhou, ChinaUniversity of Glasgow, Institute of Cardiovascular and Medical Sciences, Glasgow, United KingdomPontificia Universidade Catolica do Parana, School of Medicine, Curitiba, BrazilNational Medical Science and Nutrition Institute Salvador Zubirán, Department of Nephrology and Mineral Metabolism, Mexico City, MexicoUniversity of Copenhagen, Department of Clinical Medicine, Copenhagen, DenmarkAstraZeneca, Late-stage Development Cardiovascular Renal and Metabolism Biopharmaceuticals R&D, Gothenburg, SwedenAstraZeneca, Late-stage Development Cardiovascular Renal and Metabolism Biopharmaceuticals R&D, Gothenburg, SwedenHenry Ford Hospital- Wayne State University, Division of Nephrology and Hypertension, Detroit, United StatesAstraZeneca, Late-stage Development Cardiovascular Renal and Metabolism Biopharmaceuticals R&D, Gothenburg, SwedenUniversity College London, Department of Renal Medicine, London, United Kingdomhttp://www.sciencedirect.com/science/article/pii/S2468024921010160 |
| spellingShingle | H. Lambers Heerspink R.D. Toto N. Jongs P. Vart G.M. Chertow F.F. Hou J.J.V. McMurray R. Pecoits-Filho R. Correa-Rotter P. Rossing C.D. Sjöström B.V. Stefánsson K. Umanath A.M. Langkilde D.C. Wheeler POS-832 DAPAGLIFLOZIN IN IgA NEPHROPATHY: FINDINGS FROM THE DAPA-CKD TRIAL Kidney International Reports |
| title | POS-832 DAPAGLIFLOZIN IN IgA NEPHROPATHY: FINDINGS FROM THE DAPA-CKD TRIAL |
| title_full | POS-832 DAPAGLIFLOZIN IN IgA NEPHROPATHY: FINDINGS FROM THE DAPA-CKD TRIAL |
| title_fullStr | POS-832 DAPAGLIFLOZIN IN IgA NEPHROPATHY: FINDINGS FROM THE DAPA-CKD TRIAL |
| title_full_unstemmed | POS-832 DAPAGLIFLOZIN IN IgA NEPHROPATHY: FINDINGS FROM THE DAPA-CKD TRIAL |
| title_short | POS-832 DAPAGLIFLOZIN IN IgA NEPHROPATHY: FINDINGS FROM THE DAPA-CKD TRIAL |
| title_sort | pos 832 dapagliflozin in iga nephropathy findings from the dapa ckd trial |
| url | http://www.sciencedirect.com/science/article/pii/S2468024921010160 |
| work_keys_str_mv | AT hlambersheerspink pos832dapagliflozininiganephropathyfindingsfromthedapackdtrial AT rdtoto pos832dapagliflozininiganephropathyfindingsfromthedapackdtrial AT njongs pos832dapagliflozininiganephropathyfindingsfromthedapackdtrial AT pvart pos832dapagliflozininiganephropathyfindingsfromthedapackdtrial AT gmchertow pos832dapagliflozininiganephropathyfindingsfromthedapackdtrial AT ffhou pos832dapagliflozininiganephropathyfindingsfromthedapackdtrial AT jjvmcmurray pos832dapagliflozininiganephropathyfindingsfromthedapackdtrial AT rpecoitsfilho pos832dapagliflozininiganephropathyfindingsfromthedapackdtrial AT rcorrearotter pos832dapagliflozininiganephropathyfindingsfromthedapackdtrial AT prossing pos832dapagliflozininiganephropathyfindingsfromthedapackdtrial AT cdsjostrom pos832dapagliflozininiganephropathyfindingsfromthedapackdtrial AT bvstefansson pos832dapagliflozininiganephropathyfindingsfromthedapackdtrial AT kumanath pos832dapagliflozininiganephropathyfindingsfromthedapackdtrial AT amlangkilde pos832dapagliflozininiganephropathyfindingsfromthedapackdtrial AT dcwheeler pos832dapagliflozininiganephropathyfindingsfromthedapackdtrial |